COVID-19 in pediatric nephrology centers in Turkey

dc.authorid0000-0002-3582-5075
dc.contributor.authorLeventoğlu, Emre
dc.contributor.authorÖzdemir Atikel, Yeşim
dc.contributor.authorNalçacıoğlu, Hülya
dc.contributor.authorDursun, İsmail
dc.contributor.authorDursun, Hasan
dc.contributor.authorYürük Yıldırım, Zeynep
dc.contributor.authorYıldız, Nurdan
dc.contributor.authorKaya Aksoy, Gülşah
dc.contributor.authorTaşdemir, Mehmet
dc.contributor.authorÇelakil, Mehtap
dc.contributor.authorDemircioğlu Kılıç, Beltinge
dc.contributor.authorZırhlı Selçuk, Şena
dc.contributor.authorCanpolat, Nur
dc.contributor.authorKargın Çakıcı, Evrim
dc.contributor.authorÖzlü, Sare Gülfem
dc.contributor.authorTülpar, Sebahat
dc.contributor.authorYüksel, Selçuk
dc.contributor.authorAtmış, Bahriye
dc.contributor.authorSürmeli Döven, Serra
dc.contributor.authorTaner, Sevgin
dc.contributor.authorErtan, Pelin
dc.contributor.authorKavaz, Aslı
dc.contributor.authorTorun Bayram, Meral
dc.contributor.authorKalyoncu, Mukaddes
dc.contributor.authorGülleroğlu, Kaan
dc.contributor.authorKabasakal, Caner
dc.contributor.authorKasap Demir, Belde
dc.contributor.authorÇiçek, Rümeysa Yasemin
dc.contributor.authorBilge, İlmay
dc.contributor.authorDönmez, Osman
dc.contributor.authorKara, Aslıhan
dc.contributor.authorYavaşcan, Önder
dc.contributor.authorÖzçelik, Gül
dc.contributor.authorGezgin Yıldırım, Deniz
dc.contributor.authorGüler, Muhammet Akif
dc.contributor.authorSönmez, Ferah
dc.contributor.authorPoyrazoğlu, Hakan
dc.contributor.authorAkman, Sema
dc.contributor.authorTopaloğlu, Rezan
dc.contributor.authorAlpay, Harika
dc.contributor.authorBakkaloğlu, Sevcan Azime
dc.date.accessioned2023-01-10T07:46:02Z
dc.date.available2023-01-10T07:46:02Z
dc.date.issued2022
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
dc.description.abstractBackground/aim: There is limited data on COVID-19 disease in children with kidney disease. We aimed to investigate the characteristics and prognosis of COVID-19 in pediatric nephrology patients in Turkey. Materials and methods: This was a national, multicenter, retrospective cohort study based on an online survey evaluating the data between 11th March 2020 and 11th March 2021 as an initial step of a detailed pediatric nephrology COVID-19 registry. Results: Two hundred and three patients (89 girls and 114 boys) were diagnosed with COVID-19. One-third of these patients (36.9%) were between 10–15 years old. Half of the patients were on kidney replacement therapy: kidney transplant (KTx) recipients (n = 56, 27.5%), patients receiving chronic hemodialysis (n = 33, 16.3%) and those on peritoneal dialysis (PD) (n = 18, 8.9%). Fifty-four (26.6%) children were asymptomatic. Eighty-two (40.3%) patients were hospitalized and 23 (28%) needed intensive care unit admission. Fifty-five percent of the patients were not treated, while the remaining was given favipiravir (20.7%), steroid (16.3%), and hydroxychloroquine (11.3%). Acute kidney injury developed in 19.5% of hospitalized patients. Five (2.4%) had MIS-C. Eighty-three percent of the patients were discharged without any apparent sequelae, while 7 (3.4%) died. One hundred and eight health care staff were infected during the study period. Conclusion: COVID-19 was most commonly seen in patients who underwent KTx and received HD. The combined immunosuppressive therapy and frequent exposure to the hospital setting may increase these patients’ susceptibility. Staff infections before vaccination era were alarming, various precautions should be taken for infection control, particularly optimal vaccination coverage.
dc.identifier.citationLeventoğlu, E., Özdemir Atikel, Y., Nalçacıoğlu, H., Dursun, İ., Dursun, H., Yürük Yıldırım, Z. ... Bakkaloğlu, S. A. (2022). COVID-19 in pediatric nephrology centers in Turkey. Turkish Journal of Medical Sciences, 52(6), 1762-1770. https://dx.doi.org/10.55730/1300-0144.5521
dc.identifier.doi10.55730/1300-0144.5521
dc.identifier.endpage1770
dc.identifier.issn1300-0144
dc.identifier.issn1303-6165
dc.identifier.issue6
dc.identifier.scopus2-s2.0-85144520138
dc.identifier.scopusqualityQ3
dc.identifier.startpage1762
dc.identifier.trdizinid1145646
dc.identifier.urihttps://dx.doi.org/10.55730/1300-0144.5521
dc.identifier.urihttps://hdl.handle.net/20.500.12511/10274
dc.identifier.volume52
dc.identifier.wos000906716200003en_US
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.institutionauthorYavaşcan, Önder
dc.language.isoen
dc.publisherTurkiye Klinikleri
dc.relation.ispartofTurkish Journal of Medical Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsAttribution 4.0 International*
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectChildren
dc.subjectCOVID-19
dc.subjectKidney
dc.subjectPediatric Nephrology
dc.subjectTurkey
dc.titleCOVID-19 in pediatric nephrology centers in Turkey
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Yavascan-Onder-2022.pdf
Boyut:
133.4 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: